Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mark Russo

2PUBLICATIONS

10CO-AUTHORS

Predictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Aug 29, 2023

Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade Glioma.

Darren R Hargrave, Keita Terashima, Junichi Hara

|Nov 14, 2022

Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade Glioma.

Eric Bouffet, Birgit Geoerger, Christopher Moertel

Pageof 1

Frequent Collaborators

2 joint publications

Eric Bouffet

2 joint publications

Darren R Hargrave

1 joint publications

Birgit Geoerger

1 joint publications

James A Whitlock

1 joint publications

Elizabeth Fox

1 joint publications

Junichi Hara

1 joint publications

Uwe R Kordes

1 joint publications

Santhosh A Upadhyaya

1 joint publications

Felix Sahm

1 joint publications

Kenneth J Cohen

Frequent Collaborators

2 joint publications

Eric Bouffet

2 joint publications

Darren R Hargrave

1 joint publications

Birgit Geoerger

1 joint publications

James A Whitlock

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos